BOARD OF DIRECTORS
Carol Wallace, MD (Chair)
Dr. Wallace received her MD from the University of Michigan in 1973. She completed both her residency in pediatrics and fellowship in pediatric rheumatology at the University of Washington. Following this, she was in private practice pediatrics and rheumatology until she joined the University of Washington and Children’s Hospital and Regional Medical Center in 1984. Dr. Wallace’s main focus has been the aggressive treatment of Juvenile Idiopathic Arthritis (JIA) and other Pediatric Rheumatic Diseases. She has published many of the sentinel studies of the use of methotrexate in the treatment of JIA.
Elizabeth Mellins, MD
Professor of Pediatrics
Dr. Mellins’ lab focuses on the study of antigen presentation by major histocompatibility complex (MHC) class II molecules. She has been particularly interested in the molecular mechanisms and intracellular steps involved in the generation of complexes between MHC class II molecules and peptides. Her basic work in this area has elucidated the roles of invariant chain and HLA-DM, two molecules which regulate peptide-loading of class II molecules. She continues to study basic molecular mechanisms in antigen presentation by MHC class II molecules, focusing now on particular events in antigen presentation by B cells. In addition, the lab has an active program to understand the molecular basis of class II associations with autoimmune diseases.
Senior Vice President
Steve Russell is the Senior Vice President of People at McDonald’s USA. In this role, Mr. Russell oversees all aspects of human resources and training, learning, and development for McDonald’s 14,000 U.S. restaurants. As part of McDonald’s USA’s senior leadership team, Mr. Russell actively participates in accelerating the company’s growth, contributing to strategic direction and leading the talent management and succession planning processes. He leads the company’s efforts to fundamentally improve the capability and capacity of McDonald’s restaurants and the more than 700,000 restaurant employees.
Mr. Russell joined McDonald’s in 1996 as Director of Corporate Human Resources. In 1998, he became the Department Director of the HR Service Center and Global Technology Departments while also beginning his accelerated development program in McDonald’s Field Human Resources. Prior to his current role, Mr. Russell also served as Vice President of Human Resources for McDonald’s Business Development and Partner Brands (Boston Market, Chipotle Mexican Grill, Donatos, Fazoli’s, Pret A Manger) from 2002–2003. Mr. Russell serves on the 401k/profit sharing administration committee on behalf of McDonald’s Board of Directors. Outside of McDonald’s, Mr. Russell has served on Cornell Hospitality Research Advisory’s board and has served on the board of DisabilityWorks.
Christy Sandborg, MD
Professor of Pediatrics
The major emphasis of Dr. Sandborg’s work in the past decade has been focused on the future of academic pediatrics and pediatric rheumatology through providing training, research opportunities and environments to nurture and challenge future pediatric rheumatologists and subspecialists, and has now expanded to encompass design of new models of care for children with complex chronic illness.
Yukiko Kimura, MD Chief, Division of Pediatric Rheumatology and Professor of Pediatrics at Joseph M. Sanzari Children’s Hospital, Hackensack University Medical Center
Dr. Kimura is the chief of the Division of Pediatric Rheumatology at the Children’s Hospital at Hackensack University Medical Center, and Professor of Pediatrics at Rutgers New Jersey Medical School. Her research efforts have been directed toward improving the health, treatment and outcomes for patients with JIA and other pediatric rheumatic diseases. She is the current Chair of the Childhood Arthritis and Rheumatology Research Alliance (CARRA), President of CARRA, Inc. and co-Principal Investigator (PI) of the CARRA Registry, which is studying the long-term safety of medications being used to treat JIA. Dr Kimura led the development of the CARRA consensus treatment plans (CTPs) for both systemic JIA and polyarticular JIA, which are now being implemented through CARRA Registry-wide comparative effectiveness studies.